Corbion N.V.

Amsterdam Stock Exchange CRBN.AS

Corbion N.V. Debt to Equity Ratio for the year ending December 31, 2023: 1.23

Corbion N.V. Debt to Equity Ratio is 1.23 for the year ending December 31, 2023, a 1.76% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.

Corbion N.V. Debt to Equity Ratio for the year ending December 31, 2022 was 1.21, a 33.61% change year over year.
Corbion N.V. Debt to Equity Ratio for the year ending December 31, 2021 was 0.91, a 39.55% change year over year.
Corbion N.V. Debt to Equity Ratio for the year ending December 31, 2020 was 0.65, a -1.34% change year over year.
Corbion N.V. Debt to Equity Ratio for the year ending December 31, 2019 was 0.66, a 37.09% change year over year.

Key data

Date	Debt to Equity Ratio	Debt to Income Ratio	Debt to Tangible Net Worth Ratio	Dividend Coverage Ratio

Amsterdam Stock Exchange: CRBN.AS

Corbion N.V.

CEO	Mr. Olivier Rigaud
IPO Date	March 29, 1995
Location	Netherlands
Headquarters	Piet Heinkade 127
Employees	2,727
Sector	Health Care
Industries Biotechnology

Description

Corbion N.V. provides lactic acid and lactic acid derivatives, emulsifiers, functional enzyme blends, minerals, vitamins, and algae ingredients worldwide. The company offers ingredient solutions made from renewable resources for the food, home and personal care, pharmaceutical, animal nutrition, medical device, and bioplastics markets. It markets its products through a network of sales offices and distributors. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was founded in 1919 and is headquartered in Amsterdam, the Netherlands.

Key trends

Past 5 years